Home › Kanser sa Bile Duct
Pag-aaral pangklinika para sa Kanser sa Bile Duct na nagre-recruit sa U.S.
12 pag-aaral para sa Kanser sa Bile Duct ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
Ayos sa estado
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT04645160Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 2 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT01915225Study of Large Channel Digital Pancreaticobiliary Scope (DPS) With Compatible Accessories
Nagre-recruitPhase 4
Edad 21 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07120295PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
Nagre-recruitPhase 2
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05286814A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07186842Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT05874414Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Nagre-recruitPhase 1/2
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT05000294Integrated Cancer Repository for Cancer Research
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT05655949A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)
Nagre-recruitPhase 1/2
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT05849480Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Nagre-recruit
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Peb 20, 2026 · NCT04907643EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
Nagre-recruit
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Abr 1, 2024 · NCT06340620Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.